Skip to content

Kashtartava (Primary Dysmenorrhoea) - Ayurvedic management with Shatavari Taila Matrabasti and Tila Taila Matrabasti

A Randomized Controlled Trial to evaluate the efficacy of Shatavari Taila Matrabasti in the management of Kashtartava with special reference to Primary Dysmenorrhoea. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067335
Enrollment
120
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Preeti Kshitij Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients coming with complaint of painful menses. 2. Adolescent girls of age between 18 to 24 years. 3. Patients suffering from Kashtartava for at least 3 consecutive regular menstrual cycles. 4. Patient who agrees to participate and is ready to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years and above 24 years. 2. Married women. 3. Patients of Secondary dysmenorrhoea. 4. Patients having congenital anomaly of reproductive tract like hypoplastic uterus. 5. Patients having organic pathology of uterus and adnexa like fibroid uterus, carcinoma of endometrium. 6. Patients with Dysfunctional uterine bleeding, Pelvic Inflammatory diseases, Endometritis. 7. Patients having conditions where surgical intervention should be needed. 8.Patients with systemic diseases. 9.Patients taking hormonal therapy. 10.Patient who is not willing to give informed consent.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Shatavari Taila Matrabasti in the management of Kashtartava with special reference to Primary Dysmenorrhea on VAS scaleTimepoint: before treatment (on day 1 and day 5)and after treatment (on day 1 and day 5)

Secondary

MeasureTime frame
Effect of Shatavari Taila Matrabasti on reduction in intensity & duration of pain present in Kashtartava with special referance to Primary DysmenorrheaTimepoint: before treatment (on day 1 & day 5)and after treatment (on day 1 & day 5)

Countries

India

Contacts

Public ContactDr. Preeti Kshitij Jadhav

R.A. Podar Ayurved Medical College and Hospital

drmanojvgaikwad@gmail.com9822752816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026